These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 39296

  • 1. Inflammatory bowel disease. Part II.
    Hansen R.
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Immunomodulation treatment of inflammatory bowel disease].
    Stave R.
    Tidsskr Nor Laegeforen; 1984 Jan 30; 104(3):153-4. PubMed ID: 6142543
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec 30; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy of inflammatory bowel disease.
    Gardner RC.
    J Maine Med Assoc; 1976 Jul 30; 67(7):206-14. PubMed ID: 9461
    [No Abstract] [Full Text] [Related]

  • 7. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ.
    Semin Drug Treat; 1974 Jul 30; 3(4):339-49. PubMed ID: 4150770
    [No Abstract] [Full Text] [Related]

  • 8. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI, Present DH.
    Gastroenterology; 1981 Jan 30; 80(1):193-6. PubMed ID: 6108892
    [No Abstract] [Full Text] [Related]

  • 9. [Prevention of recurrence of chronic inflammatory bowel diseases].
    Dölle W, Hartmann F.
    Verh Dtsch Ges Inn Med; 1989 Jan 30; 95():322-6. PubMed ID: 2574922
    [No Abstract] [Full Text] [Related]

  • 10. How should we treat Crohn's disease?
    Sleisenger MH.
    N Engl J Med; 1980 May 01; 302(18):1024-6. PubMed ID: 6102738
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Imparied lymphocyte responsiveness in inflammatory bowel disease.
    Sachar DB, Taub RN, Brown SM, Present DH, Korelitz BI, Janowitz HD.
    Gastroenterology; 1973 Feb 01; 64(2):203-9. PubMed ID: 4405597
    [No Abstract] [Full Text] [Related]

  • 13. Drug management of inflammatory bowel disease.
    McCarthy CF.
    Ir Med J; 1983 May 01; 76(5):260-2. PubMed ID: 6135675
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drug treatment of inflammatory bowel disease.
    Lennard-Jones JE, Powell-Tuck J.
    Clin Gastroenterol; 1979 Jan 01; 8(1):187-217. PubMed ID: 33775
    [No Abstract] [Full Text] [Related]

  • 17. Medical therapy of inflammatory bowel disease.
    Singleton JW.
    Med Clin North Am; 1980 Nov 01; 64(6):1117-33. PubMed ID: 6109796
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The National Cooperative Crohn's Disease Study.
    MacLean LD.
    Can J Surg; 1980 Jan 01; 23(1):7-8. PubMed ID: 6102492
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.